Loading stock data…
Loading stock data…
US$0.01
Get one email when EMMA crosses your level. Checked every 15 minutes during market hours.
▼ -0.00 (-0.87%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
55.8
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.00
Bullish momentumMACD above its signal line (0.00).
50-day average
0.01
Price aboveShort-term trend reference.
200-day average
0.01
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company dedicated to the discovery, development, marketing, and sale of innovative treatments for rare and orphan diseases. The company’s flagship product, Endari, is an L-glutamine oral powder designed to reduce acute complications associated with sickle cell disease in adults and pediatric patients aged five and older. Emmaus has also developed a portfolio of pipeline products targeting conditions such as diverticulosis, blood …
www.emmausmedical.com2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2021-12-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2021-11-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2021-10-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2021-09-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-07-16 | 1.1 | 1.17 | ✓ Beat |
| 2026-03-27 | -3.78 | -0.97 | ✓ Beat |
| 2023-05-15 | -0.03 | -0.07 | ✗ Miss |
| 2023-03-31 | 0.16 | 0.01 | ✗ Miss |
| 2022-11-13 | 0.01 | -0.01 | ✗ Miss |
| 2022-08-15 | 0.01 | -0.18 | ✗ Miss |
Companies in the same industry, via Finnhub